"New era" for Milan biotech hero Arsenale Bioyards after scoring €9m in funding

Arsenale's founders – Matteo Zanotto, Gordana Djordjevic, Massimo Portincaso, Niels Agerbaek and Arnaud Legris. Photo: Press image.
25 feb. 2025
16:01
Arsenale's founders – Matteo Zanotto, Gordana Djordjevic, Massimo Portincaso, Niels Agerbaek and Arnaud Legris. Photo: Press image.
Arsenale Bioyards hopes to ramp up the commercialisation of bio-manufacturing. Now its own journey has been accelerated by a major seed funding round led by Nordic and German investors.

With a broad goal of redefining scalable biomanufacturing, Milan-based Arsenale Bioyards has just announced it is taking in €9m ($10m) to work on its mission, after successfully closing its first seed financing round.

Arsenale's platform combines advanced lab and industrial-scale bioreactors with AI-driven software, optimising fermentation processes and increasing the speed of scaling from lab to industrial scale.

Become a member to continue reading